These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4049328)

  • 1. Antihemostatic and antithrombotic effects of XC386.
    Wang JP; Hsu MF; Huang LJ
    Thromb Res; 1985 Aug; 39(4):501-10. PubMed ID: 4049328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihemostatic and antithrombotic effects of capsaicin in comparison with aspirin and indomethacin.
    Wang JP; Hsu MF; Hsu TP; Teng CM
    Thromb Res; 1985 Mar; 37(6):669-79. PubMed ID: 3992533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hsien-ho-t'sao (Agrimonia pilosa) on experimental thrombosis in mice.
    Hsu MF; Young JH; Wang JP; Teng CM
    Am J Chin Med; 1987; 15(1-2):43-51. PubMed ID: 3687839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XC 386: a new antiplatelet agent.
    Wang JP; Hsu MF; Tsai HY; Huang LJ; Teng CM
    Thromb Res; 1984 Oct; 36(2):113-22. PubMed ID: 6438827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis.
    Makkar RR; Litvack F; Eigler NL; Nakamura M; Ivey PA; Forrester JS; Shah PK; Jordan RE; Kaul S
    Circulation; 1997 Feb; 95(4):1015-21. PubMed ID: 9054765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
    Teng CM; Wu CC; Ko FN; Lee FY; Kuo SC
    Eur J Pharmacol; 1997 Feb; 320(2-3):161-6. PubMed ID: 9059849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of "anti-platelet" drugs on bleeding time and platelet aggregation in normal human subjects.
    Buchanan GR; Martin V; Levine PH; Scoon K; Handin RI
    Am J Clin Pathol; 1977 Sep; 68(3):355-9. PubMed ID: 331937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice.
    Sheu JR; Chao SH; Yen MH; Huang TF
    Thromb Haemost; 1994 Oct; 72(4):617-21. PubMed ID: 7878641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis.
    André P; LaRocca T; Delaney SM; Lin PH; Vincent D; Sinha U; Conley PB; Phillips DR
    Circulation; 2003 Nov; 108(21):2697-703. PubMed ID: 14597584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total steroidal alkaloids from Veratrum patulum L. Inhibit platelet aggregation, thrombi formation and decrease bleeding time in rats.
    Song Q; Wang S; Zhao W
    J Ethnopharmacol; 2012 May; 141(1):183-6. PubMed ID: 22366682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of the combination of aspirin and nifedipine on platelet aggregation and thrombogenesis].
    Dong E; Shi S
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Oct; 18(5):301-3, 319. PubMed ID: 2086198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo method for quantitation for anti-platelet potency of drugs.
    Gryglewski RJ; Korbut R; Ocetkiewicz A; Stachura J
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Mar; 302(1):25-30. PubMed ID: 652049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.
    Turner NA; Moake JL; Kamat SG; Schafer AI; Kleiman NS; Jordan R; McIntire LV
    Circulation; 1995 Mar; 91(5):1354-62. PubMed ID: 7867173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxic shock in the primate: effects of aspirin and dipyridamole administration.
    Rao PS; Cavanagh D; Gaston LW
    Am J Obstet Gynecol; 1981 Aug; 140(8):914-22. PubMed ID: 7270604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of aspirin or heparin on platelet function and postoperative blood loss after coronary artery bypass surgery.
    Sirvinskas E; Veikutiene A; Grybauskas P; Cimbolaityte J; Mongirdiene A; Veikutis V; Raliene L
    Perfusion; 2006 Jan; 21(1):61-6. PubMed ID: 16485701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
    Karnicki K; Leadley RJ; Baxi S; Peterson T; Wysokinski W; McBane RD
    Thromb Haemost; 2008 Apr; 99(4):759-66. PubMed ID: 18392334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet and antithrombotic activities of NQ301, 2-chloro-3-(4-acetophenyl)-amino-1,4-naphthoquinone.
    Kang WS; Ryu CK; Chung KH; Ko MW; Joo JC; Yuk DY; Yoo HS; Yun YP
    Biol Pharm Bull; 1999 Dec; 22(12):1284-7. PubMed ID: 10746156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the antithrombotic activity of Zhi-Xiong Capsules, a Traditional Chinese Medicinal formula, via the pathway of anti-coagulation, anti-platelet activation and anti-fibrinolysis.
    Zhou J; Song Z; Han M; Yu B; Lv G; Han N; Liu Z; Yin J
    Biomed Pharmacother; 2018 Jan; 97():1622-1631. PubMed ID: 29793324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute thrombogenicity of arterial prostheses exposed to reduced blood flow in dogs: effects of heparin, aspirin, and prostacyclin.
    Merhi Y; Bernier J; Marois Y; Guidoin R
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):1-5. PubMed ID: 7564348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of acute stent thrombosis under high-shear flow conditions by a nitric oxide donor, DMHD/NO. An ex vivo porcine arteriovenous shunt study.
    Kaul S; Makkar RR; Nakamura M; Litvack FI; Shah PK; Forrester JS; Hutsell TC; Eigler NL
    Circulation; 1996 Nov; 94(9):2228-34. PubMed ID: 8901676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.